4.7 Review

Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis

R. Pal et al.

Summary: The study found that vitamin D supplementation may be associated with improved clinical outcomes in COVID-19 patients, especially when administered post-diagnosis. However, questions regarding the appropriate dose, duration, and mode of administration of vitamin D remain unanswered and require further research.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Article Medicine, General & Internal

Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)

Ashu Rastogi et al.

Summary: This study investigates the effect of high-dose oral cholecalciferol supplementation on SARS-CoV-2 viral clearance. The results show that supplementation with cholecalciferol can increase the proportion of vitamin D-deficient individuals who become SARS-CoV-2 RNA negative and reduce fibrinogen levels.

POSTGRADUATE MEDICAL JOURNAL (2022)

Review Food Science & Technology

Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis

Marcos Pereira et al.

Summary: This systematic review and meta-analysis found that vitamin D deficiency is associated with a higher prevalence in severe cases of COVID-19. Vitamin D insufficiency is also linked to increased hospitalization and mortality from COVID-19.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Review Endocrinology & Metabolism

Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis

Dimple Rawat et al.

Summary: A meta-analysis showed that vitamin-D supplementation did not significantly improve mortality, ICU admission rates, or need for invasive ventilation in COVID-19 patients. Further well-designed RCTs are needed to address this topic.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Article Medicine, General & Internal

Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis

K. Shah et al.

Summary: The meta-analysis suggests that vitamin D supplementation may reduce ICU requirement in hospitalized COVID-19 patients, but has comparable effect on mortality when compared to placebo treatment. More robust data from randomized controlled trials are needed to further evaluate its effects.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)

Article Nutrition & Dietetics

Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study

Sandro Giannini et al.

Summary: This retrospective study aimed to examine the clinical outcome of hospitalized COVID-19 patients receiving high-dose cholecalciferol treatment. The study found that the therapeutic effect of vitamin D treatment on COVID-19 patients may be significantly impacted by the burden of comorbidities.

NUTRIENTS (2021)

Article Nutrition & Dietetics

Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank

Hao Ma et al.

Summary: The habitual use of vitamin D supplements is associated with a lower risk of COVID-19 infection, with no significant association found between circulating or genetically predicted vitamin D levels and the risk of infection. Further clinical trials are needed to confirm these results and rule out potential confounding factors.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2021)

Article Biochemistry & Molecular Biology

Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study

Cedric Annweiler et al.

Summary: The study found that supplementation of vitamin D3 prior to or during COVID-19 was associated with better 3-month survival in geriatric patients hospitalized for COVID-19. The intervention group had a significantly higher survival rate at 3 months compared to the comparator group, with a lower hazard ratio for 3-month mortality.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)

Article Medicine, General & Internal

Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19 A Randomized Clinical Trial

Igor H. Murai et al.

Summary: The study found that a single high dose of vitamin D-3 did not significantly reduce hospital length of stay among hospitalized patients with COVID-19. The findings do not support the use of a high dose of vitamin D-3 for treatment of moderate to severe COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Endocrinology & Metabolism

Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials

David A. Jolliffe et al.

Summary: Vitamin D supplementation was found to be safe and reduce the risk of acute respiratory infections, especially when administered in daily doses of 400-1000 IU for up to 12 months and to participants aged 1.00-15.99 years. However, the relevance of these findings to COVID-19 is uncertain and further investigation is needed.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Biochemistry & Molecular Biology

Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study

Joaquim Oristrell et al.

Summary: The study suggests that calcitriol supplementation may benefit patients with advanced chronic kidney disease in reducing the risk of infection, severe illness, and mortality during the COVID-19 pandemic.

BIOMEDICINES (2021)

Article Nutrition & Dietetics

The effect of high-dose parenteral vitamin D3 on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: an observational cohort study

Mehmet Guven et al.

Summary: This study aimed to investigate the relationship between clinical course and inhospital mortality with high-dose vitamin D-3 administration within the first 24 hours of admission for COVID-19 ICU patients with vitamin D deficiency. The results showed that parenteral administration of high-dose vitamin D-3 did not reduce the need for intubation, length of hospital stay, and inhospital mortality in critically ill COVID-19 patients with vitamin D deficiency.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2021)

Article Endocrinology & Metabolism

Calcifediol Treatment and COVID-19-Related Outcomes

Xavier Nogues et al.

Summary: The study aimed to elucidate the effect of calcifediol treatment on COVID-19 outcomes. The findings showed that in hospitalized patients with COVID-19, calcifediol treatment significantly reduced ICU admission and mortality.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Nutrition & Dietetics

Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study

Juan F. Alcala-Diaz et al.

Summary: A study in five hospitals in the South of Spain found that COVID-19 patients who received oral calcifediol treatment had significantly lower in-hospital mortality during the first 30 days compared to those who did not receive the treatment.

NUTRIENTS (2021)

Article Nutrition & Dietetics

Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial

Shaun Sabico et al.

Summary: The study demonstrated that daily supplementation of 5000 IU vitamin D3 for two weeks significantly increased serum 25(OH)D levels. Additionally, the 5000 IU group had a shorter recovery time for cough and loss of taste compared to the 1000 IU group.

NUTRIENTS (2021)

Article Multidisciplinary Sciences

被撤回的出版物: Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease (Retracted article. See vol. 12, 2022)

Maheshwar Lakkireddy et al.

Summary: This study investigated the impact of Pulse D therapy on reducing inflammatory markers of COVID-19. The results showed a significant reduction in inflammatory markers in the VD group after receiving Pulse D therapy, while the reduction in the NVD group was not significant.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study

Guillaume Butler-Laporte et al.

Summary: This study utilized Mendelian randomization to investigate the relationship between increased vitamin D levels and COVID-19 outcomes. The results consistently showed no evidence supporting an association between genetically predicted vitamin D levels and COVID-19 susceptibility, severity, or hospitalization. Other therapeutic or preventative avenues should be prioritized for COVID-19 randomized controlled trials based on these findings.

PLOS MEDICINE (2021)

Article Medicine, General & Internal

Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation

Gabriela Athziri Sanchez-Zuno et al.

Summary: The study found that vitamin D deficiency in COVID-19 outpatients is associated with disease severity, and vitamin D supplementation can alleviate symptoms and increase serum concentrations.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Effect of Vitamin D Supplementation on Muscle Status in Old Patients Recovering from COVID-19 Infection

Alberto Caballero-Garcia et al.

Summary: Vitamin D supplementation may reduce indicators of muscle damage in elderly COVID-19 patients during the recovery phase, potentially contributing to improvements in their health status and quality of life.

MEDICINA-LITHUANIA (2021)

Review Pharmacology & Pharmacy

The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis

Leila Nikniaz et al.

Summary: Vitamin D supplementation has a positive impact on COVID-19 patients, reducing mortality rate, severity of the disease, and levels of inflammatory markers. Further research is needed to determine the optimal type, dosage, and duration of supplementation.

PHARMACEUTICAL SCIENCES (2021)

Article Medicine, General & Internal

COVID-19 severity in relation to sociodemographics and vitamin D use

Darya Saeed Abdulateef et al.

Summary: This study aimed to evaluate the severity of COVID-19, and found that stress, age, and presence of comorbidities were significant positive predictors of severity, while prophylactic vitamin D use and smoking were significant negative predictors. Additionally, the use of protective measures and other prophylactic dietary supplements was not significantly associated with symptom severity.

OPEN MEDICINE (2021)

Article Endocrinology & Metabolism

Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection

Jose L. Hernandez et al.

Summary: The study found that hospitalized COVID-19 patients have significantly lower serum 25OHD levels than population-based controls, and the prevalence of vitamin D deficiency is higher in COVID-19 patients. However, no relationship was found between vitamin D concentrations or deficiency and the severity of the disease at this time.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Biochemistry & Molecular Biology

Vitamin D and survival in COVID-19 patients: A quasi-experimental study

Cedric Annweiler et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)

Article Medicine, General & Internal

Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results

David O. Meltzer et al.

JAMA NETWORK OPEN (2020)

Review Health Care Sciences & Services

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)